Special report: left ventricular assist devices as destination therapy for end-stage heart failure--cost-effectiveness analysis.

Special report: left ventricular assist devices as destination therapy for end-stage heart failure--cost-effectiveness analysis. [electronic resource] - TEC bulletin Nov 2003 - 33-4 p. digital

Publication Type: Journal Article

1543-1622


Blue Cross Blue Shield Insurance Plans
Cost-Benefit Analysis
Device Approval
Drug Approval
Evidence-Based Medicine
Heart Failure--surgery
Heart Transplantation
Heart-Assist Devices--economics
Humans
Insurance Coverage
Outcome Assessment, Health Care
Technology Assessment, Biomedical
United States
United States Food and Drug Administration